Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas

• Motonobu Saito,

  Affiliations Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan

  ⨯
• Kensuke Kumamoto,

  Affiliations Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan

  ⨯
• Ana I. Robles,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Izumi Horikawa,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Bungo Furusato,

  Affiliation Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, D.C., United States of America

  ⨯
• Shu Okamura,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Akiteru Goto,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Taro Yamashita,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Makoto Nagashima,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Tin-Lap Lee,

  Affiliation Laboratory of Clinical and Developmental Genomics, Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Vanessa J. Baxendale,

  Affiliation Laboratory of Clinical and Developmental Genomics, Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Owen M. Rennert,

  Affiliation Laboratory of Clinical and Developmental Genomics, Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Seiichi Takenoshita,

  Affiliation Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan

  ⨯
• Jun Yokota,

  Affiliation Biology Division, National Cancer Center Research Institute, Tokyo, Japan

  ⨯
• Isabell A. Sesterhenn,

  Affiliation Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, D.C., United States of America

  ⨯
• Glenwood E. Trivers,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• S. Perwez Hussain,

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Curtis C. Harris

  * E-mail: curtis_harris@nih.gov

  Affiliation Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]